Reduced Aph-1b expression causes tissue- and substrate-specific changes in gamma-secretase activity in rats with a complex phenotype. by Coolen, M.W. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/32917
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
The FASEB Journal • FJ Express
Reduced Aph-1b expression causes tissue- and
substrate-specific changes in -secretase activity
in rats with a complex phenotype
Marcel W. Coolen,* Karen M.J. van Loo,* Nick N.H.M. van Bakel,*
Bart A. Ellenbroek,† Alexander R. Cools,† and Gerard J. M. Martens*,1
*Department of Molecular Animal Physiology-Nijmegen Center for Molecular Life Sciences
(NCMLS) and Institute for Neuroscience-Radboud University of Nijmegen, The Netherlands;
†Department of Psychoneuropharmacology-UMC St. Radboud, Nijmegen, The Netherlands
To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.05-4337fje;
doi: 10.1096/fj.05-4337fje
SPECIFIC AIMS
The -secretase enzyme is a tetrameric protein complex
consisting of presenilin-1 (or -2), nicastrin, PEN-2, and
Aph-1a (or -1b), and displays intramembrane catalytic
activity toward a number of type I transmembrane
proteins that are involved in a variety of (neuro)devel-
opmental signaling pathways. The aim of this study was
to examine the functional consequences of a gene-
dosage imbalance of a -secretase component, namely
the effect of the presence of only one copy or three
copies of the rat Aph-1b gene on the level of -secretase
cleavage activity toward various endogenous substrates.
PRINCIPAL FINDINGS
1. Reduced Aph-1b expression levels are not
compensated by its paralog Aph-1a
Using Northern blot analysis, we detected high levels of
Aph-1b mRNA in most tissues from rats with three
copies of the gene encoding the -secretase component
Aph-1b (III/III rats), whereas in the same tissues from
rats with one Aph-1b gene copy (I/I rats) the levels were
not or hardly above background. In contrast, the
mRNA levels of the paralogs Aph-1aS and -1aL did not
differ between I/I and III/III rat tissues, also not in the
tissues with large differences in Aph-1b expression.
Furthermore, the ratios between the Aph-1b and Aph-1a
mRNA levels greatly varied among the III/III rat tis-
sues. Tissues such as the olfactory bulb, pons/medulla,
testis and lung showed high Aph-1b/-1a ratios, while the
cortex, hippocampus, spinal cord, stomach, large intes-
tine and thymus had moderate ratios, and the cerebel-
lum, striatum, (hypo)thalamus, eye, heart, muscle,
small intestine, spleen, liver and pancreas displayed low
ratios (Fig. 1). Real-time quantitative RT-PCR analysis
revealed significant reductions in Aph-1b mRNA levels
in cerebellum, olfactory bulb, cortex, and lung from I/I
compared with III/III rats (P0.05), with the largest
difference observed for the olfactory bulb (8-fold
reduction). In contrast, the Aph-1a mRNA levels did not
differ between the two rat lines in the tissues analyzed.
The Aph-1b/-1a ratios determined by PCR were similar
to those obtained through Northern blot analysis (high
Aph-1b/-1a ratio in olfactory bulb and lung, moderate
ratio in cortex and low ratio in cerebellum).
2. Tissue- and substrate-specific alterations in
-secretase cleavage activity in rats with reduced
Aph-1b levels
Since the Aph-1 protein is an essential component of
the -secretase complex, we were interested in the
effect of the differential mRNA expression of Aph-1b on
the proteolytic cleavage activity of the complex in I/I
and III/III rat tissues. To this end, the levels of cleavage
products of various -secretase substrates were exam-
ined by Western blot analysis using antibodies directed
against the C-terminal regions of the substrates. In
general, the proteolytic processing of a -secretase
substrate starts with shedding of its extracellular do-
main, leaving a C-terminal fragment (CTF) that is
subsequently cleaved by -secretase to its intracellular
domain (ICD). One of the best known substrates of
-secretase is the Alzheimer’s disease-linked amyloid-
precursor protein (APP). APP is part of the APP
superfamily that in mammals includes the two APP-like
proteins APLP1 and APLP2. We compared the -secre-
tase cleavage activities toward the APP superfamily
members in tissues of III/III rats having different
Aph-1b/-1a ratios (high: olfactory bulb and lung; mod-
erate: spinal cord and cortex; low: [hypo]thalamus,
cerebellum and spleen) with the activities in the corre-
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sponding I/I rat tissues. The levels of the direct -secre-
tase substrates (CTFs) were significantly increased in
the olfactory bulb (APP: 1.6-fold [P0.01]; APLP1:
2.0-fold [P0.05]; APLP2: 2.1-fold [P0.05]), the lung
(APP: 2.2-fold [P0.05]; APLP2: 1.3-fold [P0.05]),
the spinal cord (APP: 1.6-fold [P0.02]; APLP1: 1.6-
fold [P0.05]; APLP2: 1.8-fold [P0.05]) and the cortex
(APP: 1.3-fold [P0.05]; APLP2: 2.2-fold [P0.02]) of I/I
compared with III/III rats. No significant differences in
the CTF levels were observed in the (hypo)thalamus,
cerebellum, and spleen of I/I and III/III rats, i.e., in
tissues with a low Aph-1b/-1a ratio (Fig. 2).
We next analyzed the cleavage products of the
-secretase substrates neurotrophin receptor p75, the
neuregulin receptor ErbB4, and neuregulin-2 (NRG2).
The levels of p75-CTF were similar in all I/I and III/III
rat tissues tested, whereas p75-ICD showed significantly
reduced levels only in the olfactory bulb of the I/I rats
(1.8-fold [P0.05]). The olfactory bulb was also the
only tissue with significantly reduced ErbB4-ICD levels
when comparing I/I and III/III rat tissues (1.3-fold
[P0.05]). The CTF levels of NRG2 were similar in all
tissues examined.
CONCLUSIONS AND SIGNIFICANCE
The -secretase enzyme complex requires at least four
protein components to display cleavage activity: prese-
nilin (PS-1 or -2), nicastrin, PEN-2, and Aph-1 (Aph-
1aS, -1aL, or -1b). We examined the mRNA expression
levels of Aph-1aS, -1aL, and Aph-1b and the effects of the
differential Aph-1b expression on the cleavage activity of
the -secretase complex in rats with one or three Aph-1b
gene copies (I/I and III/III rats, respectively). In III/III
rat tissues, ratios between the Aph-1b and -1a mRNA
levels varied greatly. A reduction in Aph-1b gene copy
numbers in the I/I rats was accompanied by a large
drop in Aph-1b mRNA expression levels, not compen-
sated for by its paralog Aph-1a. The reduced expression
Figure 1. Northern blot analysis of Aph-1a and -1b mRNA
expression in various tissues of I/I and III/III rats. The Aph-1a
probe detected both the short and long isoform (Aph-1aS and
-1aL, respectively). The Aph-1b/-1a ratio was determined for
every III/III rat tissue and categorized as high (Aph-1b/-
1a2.0; ), moderate (1.0Aph-1b/-1a2.0;) or low
(Aph-1b/1a1.0; ). Tissues used were cerebellum (cer),
olfactory bulb (olf), cortex (ctx), hippocampus (hip), stria-
tum (str), (hypo)thalamus (tha), pons/medulla (p/m), spi-
nal cord (spc), eye, testis (tes), heart, (hrt), muscle (msc),
stomach (sto), small intestine (s.i.), large intestine (l.i.), lung
(lng), spleen (spl), liver (liv), thymus (thy), and pancreas
(pan) of PND9 III/III (3) or I/I (1) rats.
Figure 2. Western blot analysis of the -secretase cleavage
products derived from the APP, APLP1 and APLP2 proteins in
various tissues of I/I and III/III rats. A) Levels of C-terminal
fragments (CTFs) of amyloid- precursor protein (APP), and
the APP-like proteins APLP1 and APLP2 (sizes of all 3 CTFs10
kDa) were analyzed in neuronal tissues of PND13 I/I (1) and
III/III (3) rats using specific antibodies. Tissues used were the
olfactory bulb (high Aph-1b/-1a ratio), spinal cord, and cortex
(moderate ratio), and (hypo)thalamus and cerebellum (low
ratio). B) Levels of APP-CTF, APLP1-CTF and APLP2-CTF were
analyzed in the lung (high Aph-1b/-1a ratio) and spleen (low
ratio) of PND13 I/I and III/III rats. In each case, tubulin (55
kDa) was used for normalization. Bars represent quantifications
in arbitrary units of normalized CTF signals of 5 tissue samples
with the average level in III/III rat tissues set to 1. The levels of
the APP, APLP1 and APLP2 holoproteins were similar in the I/I
and III/III rat tissues. *P  0.05; **P  0.02; ***P  0.01; n 
5, with the 5 rats per genotype from different nests; plus sem;
BD: below detection.
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resulted in substrate- and tissue-specific alterations in
-secretase cleavage activity (Fig. 3). Tissues that nor-
mally have a high Aph-1b/-1a ratio displayed clear
differences in -secretase cleavage activity, whereas the
activity in tissues with a low ratio was either hardly
affected or not at all. Within a particular tissue, sub-
strate processing was not affected to the same extent,
showing that -secretase complexes with different sub-
unit compositions are not functionally redundant and
that a specific complex is involved in the preferential
cleavage of a subset of -secretase substrates.
We earlier found that the Aph-1b rat genotypes seg-
regated with behavioral phenotypes, and rats with a
natural Aph-1b knockdown (APO-SUS) display alter-
ations in brain information processing (prepulse inhi-
bition and latent inhibition), locomotor activity in
response to novelty, fleeing, and problem-solving be-
havior, and HPA-axis response to stress. The APO-SUS
phenotype partially overlaps with the behavioral phe-
notypes of a number of mouse models with altered
expression of a -secretase substrate. For example,
heterozygous ErbB4 or NRG1 knockout mice (with an
overall 50% reduction of mRNA expression) are also
hyperactive in an open field and show an impaired
prepulse inhibition, whereas reduced expression of
Notch has no effect on the open field behavior. Con-
versely, overexpression of human APP751 or APP-CTF
caused a general hypoactivity in mice.
In our studies, we further found that of the brain
tissues examined, the olfactory bulb of the I/I rats
displayed the most severely affected -secretase cleav-
age activity. Removal of the olfactory bulb from normal
rats resulted in a model for agitated depression. These
rats displayed alterations in behavior, and in the func-
tioning of the HPA-axis, the immune system, thymus
and spleen weight, and self-administration of drugs.
These phenotypic features are also observed in APO-
SUS rats. Furthermore, human neurological disorders
such as Alzheimer’s disease and schizophrenia are
characterized by olfactory dysfunction. Still, it is not
clear to what extent differences in -secretase cleavage
activity found in tissues other than the olfactory bulb,
such as the cortex, spinal cord, and lung, have also
contributed to the complex phenotype of the APO-SUS
rats.
In conclusion, the differential expression of Aph-1b in
the I/I and III/III rats caused subtle, substrate-specific
alterations in -secretase cleavage activity toward a
numer of -secretase substrates, especially in tissues
with a relatively high Aph-1b level (Fig. 3). Thus, a single
gene defect may affect a great variety of (neuro)devel-
opmental signaling pathways, resulting in a complex
phenotype that is generally thought to have a multi-
genic origin. Furthermore, the -secretase complex,
generally known because it is linked to Alzheimer’s
disease (a neurodegenerative and ageing disorder),
may also be associated with (neuro)developmental dis-
orders that become apparent much earlier in life.
Figure 3. Schematic representation of the tissue- and sub-
strate-specific changes in -secretase activity upon reduced
expression of Aph-1b, affecting a great variety of signaling
pathways and resulting in a complex phenotype. Reduction of
Aph-1b levels (in I/I compared with III/III rats) causes
changes in -secretase complex compositions; complexes
containing Aph-1b (termed 1b) become less available
(smaller hexagonal sizes) and Aph-1a containing complexes
remain unaffected (1a; same hexagonal sizes). These changes
affect -secretase cleavage activity (indicated by changes in
arrow thickness), but toward a limited number of substrates
and only in certain tissues. Circle sizes reflect the different
substrate levels in the various tissues and the thickness of the
arrows corresponds to activity toward a specific substrate. For
clarity, only 2 types of -secretase complexes (1a and 1b) and
6 substrates (A–F) are shown; in mammals, 6 -secretase
complexes with different subunit compositions can be
formed;  15 substrates are known so far. The reduced
expression of a single gene (Aph-1b) results in a complex
phenotype, thought to have a multigenic origin.
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